Rationale: Early, accurate diagnosis of interstitial lung disease (ILD) informs prognosis and therapy, especially in idiopathic pulmonary fibrosis (IPF). Current diagnostic methods are imperfect. High-resolution computed tomography has limited resolution, and surgical lung biopsy (SLB) carries risks of morbidity and mortality. Endobronchial optical coherence tomography (EB-OCT) is a low-risk, bronchoscope-compatible modality that images large lung volumes in vivo with microscopic resolution, including subpleural lung, and has the potential to improve the diagnostic accuracy of bronchoscopy for ILD diagnosis. Objectives: We performed a prospective diagnostic accuracy study of EB-OCT in patients with ILD with a low-confidence diagnosis undergoing SLB. The primary endpoints were EB-OCT sensitivity/specificity for diagnosis of the histopathologic pattern of usual interstitial pneumonia (UIP) and clinical IPF. The secondary endpoint was agreement between EB-OCT and SLB for diagnosis of the ILD fibrosis pattern. Methods: EB-OCT was performed immediately before SLB. The resulting EB-OCT images and histopathology were interpreted by blinded, independent pathologists. Clinical diagnosis was obtained from the treating pulmonologists after SLB, blinded to EB-OCT. Measurements and Main Results: We enrolled 31 patients, and 4 were excluded because of inconclusive histopathology or lack of EB-OCT data. Twenty-seven patients were included in the analysis (16 men, average age: 65.0 yr): 12 were diagnosed with UIP and 15 with non-UIP ILD. Average FVC and DlCO were 75.3% (SD, 18.5) and 53.5% (SD, 16.4), respectively. Sensitivity and specificity of EB-OCT was 100% (95% confidence interval, 75.8-100.0%) and 100% (79.6-100%), respectively, for both histopathologic UIP and clinical diagnosis of IPF. There was high agreement between EB-OCT and histopathology for diagnosis of ILD fibrosis pattern (weighted κ: 0.87 [0.72-1.0]). Conclusions: EB-OCT is a safe, accurate method for microscopic ILD diagnosis, as a complement to high-resolution computed tomography and an alternative to SLB.
Rationale: Early, accurate diagnosis of interstitial lung disease (ILD) informs prognosis and therapy, especially in idiopathic pulmonary fibrosis (IPF). Current diagnostic methods are imperfect. High-resolution computed tomography has limited resolution, and surgical lung biopsy (SLB) carries risks of morbidity and mortality. Endobronchial optical coherence tomography (EB-OCT) is a low-risk, bronchoscope-compatible modality that images large lung volumes in vivo with microscopic resolution, including subpleural lung, and has the potential to improve the diagnostic accuracy of bronchoscopy for ILD diagnosis. Objectives: We performed a prospective diagnostic accuracy study of EB-OCT in patients with ILD with a low-confidence diagnosis undergoing SLB. The primary endpoints were EB-OCT sensitivity/specificity for diagnosis of the histopathologic pattern of usual interstitial pneumonia (UIP) and clinical IPF. The secondary endpoint was agreement between EB-OCT and SLB for diagnosis of the ILD fibrosis pattern. Methods: EB-OCT was performed immediately before SLB. The resulting EB-OCT images and histopathology were interpreted by blinded, independent pathologists. Clinical diagnosis was obtained from the treating pulmonologists after SLB, blinded to EB-OCT. Measurements and Main Results: We enrolled 31 patients, and 4 were excluded because of inconclusive histopathology or lack of EB-OCT data. Twenty-seven patients were included in the analysis (16 men, average age: 65.0 yr): 12 were diagnosed with UIP and 15 with non-UIP ILD. Average FVC and DlCO were 75.3% (SD, 18.5) and 53.5% (SD, 16.4), respectively. Sensitivity and specificity of EB-OCT was 100% (95% confidence interval, 75.8-100.0%) and 100% (79.6-100%), respectively, for both histopathologic UIP and clinical diagnosis of IPF. There was high agreement between EB-OCT and histopathology for diagnosis of ILD fibrosis pattern (weighted κ: 0.87 [0.72-1.0]). Conclusions: EB-OCT is a safe, accurate method for microscopic ILD diagnosis, as a complement to high-resolution computed tomography and an alternative to SLB.
Entities:
Keywords:
idiopathic pulmonary fibrosis; interstitial lung disease; in vivo microscopy; in vivo optical imaging; usual interstitial pneumonia
Authors: Robert Brownell; Teng Moua; Travis S Henry; Brett M Elicker; Darin White; Eric Vittinghoff; Kirk D Jones; Anatoly Urisman; Carlos Aravena; Kerri A Johannson; Jeffrey A Golden; Talmadge E King; Paul J Wolters; Harold R Collard; Brett Ley Journal: Thorax Date: 2017-01-12 Impact factor: 9.139
Authors: Seok H Yun; Guillermo J Tearney; Benjamin J Vakoc; Milen Shishkov; Wang Y Oh; Adrien E Desjardins; Melissa J Suter; Raymond C Chan; John A Evans; Ik-Kyung Jang; Norman S Nishioka; Johannes F de Boer; Brett E Bouma Journal: Nat Med Date: 2006-11-19 Impact factor: 53.440
Authors: Ganesh Raghu; David Lynch; J David Godwin; Richard Webb; Thomas V Colby; Kevin O Leslie; Juergen Behr; Kevin K Brown; James J Egan; Kevin R Flaherty; Fernando J Martinez; Athol U Wells; Lixin Shao; Huafeng Zhou; Patricia S Pedersen; Rohit Sood; A Bruce Montgomery; Thomas G O'Riordan Journal: Lancet Respir Med Date: 2014-02-18 Impact factor: 30.700
Authors: Carlo Albera; Ulrich Costabel; Elizabeth A Fagan; Marilyn K Glassberg; Eduard Gorina; Lisa Lancaster; David J Lederer; Steven D Nathan; Dominique Spirig; Jeff J Swigris Journal: Eur Respir J Date: 2016-07-28 Impact factor: 16.671
Authors: Ulrich Costabel; Yoshikazu Inoue; Luca Richeldi; Harold R Collard; Inga Tschoepe; Susanne Stowasser; Arata Azuma Journal: Am J Respir Crit Care Med Date: 2016-01-15 Impact factor: 21.405
Authors: David A Lynch; Nicola Sverzellati; William D Travis; Kevin K Brown; Thomas V Colby; Jeffrey R Galvin; Jonathan G Goldin; David M Hansell; Yoshikazu Inoue; Takeshi Johkoh; Andrew G Nicholson; Shandra L Knight; Suhail Raoof; Luca Richeldi; Christopher J Ryerson; Jay H Ryu; Athol U Wells Journal: Lancet Respir Med Date: 2017-11-15 Impact factor: 30.700
Authors: David C Adams; Alyssa J Miller; Matthew B Applegate; Josalyn L Cho; Daniel L Hamilos; Alex Chee; Jasmin A Holz; Margit V Szabari; Lida P Hariri; R Scott Harris; Jason W Griffith; Andrew D Luster; Benjamin D Medoff; Melissa J Suter Journal: Respirology Date: 2019-03-07 Impact factor: 6.424
Authors: Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble Journal: N Engl J Med Date: 2014-05-18 Impact factor: 91.245
Authors: Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard Journal: N Engl J Med Date: 2014-05-18 Impact factor: 91.245
Authors: Christina Bal; Casper Falster; Andre Carvalho; Nicole Hersch; Judith Brock; Christian B Laursen; Simon Walsh; Jouke Annema; Daniela Gompelmann Journal: ERJ Open Res Date: 2022-05-23